# Gedeon Richter

Gedeon Richter is an Asset Manager based in Budapest, Hungary.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Budapest, Hungary
- **Region:** North America
- **Address:** Gyömrői út 19-21, Budapest, 1103, Hungary
- **Founded:** 1901
- **Assets under management:** Undisclosed
- **Website:** gedeonrichter.com
- **LinkedIn:** https://www.linkedin.com/company/gedeonrichter

## Regulatory record

- **Reports private funds:** No

## About

Gedeon Richter is a pharmaceutical company founded in 1901 in Budapest, Hungary. It develops, manufactures, and markets medicines across various therapeutic areas. Its portfolio includes originator, generic, and licensed products for the central nervous system, cardiovascular system, and gynecological health.

## Sectors

- Healthcare Services

## People

- Gábor Orbán — CEO

## Questions

### What is Gedeon Richter's core therapeutic focus?

Richter concentrates on women's healthcare, central nervous system disorders, and biosimilars. Its women's health portfolio includes oral contraceptives and emergency contraception, while CNS products cover schizophrenia, bipolar disorder, and epilepsy. The biosimilar program targets oncology and immunology products, developed through partnerships including its joint venture with Helm AG.

### Is Gedeon Richter a contract manufacturer or a branded pharmaceutical company?

Richter operates primarily as a branded specialty pharmaceutical and generics manufacturer with its own intellectual property and R&D pipeline. While it does produce active pharmaceutical ingredients and finished doses for its own products, it is not a pure contract manufacturer. Its business model centers on developing, registering, and commercializing its own drug portfolio.

### How does the Hungarian government's ownership stake influence Richter's strategy?

The Hungarian state holds a significant ownership position, placing Richter within a semi-strategic national context. This means the company balances commercial objectives with national pharmaceutical supply considerations, particularly for the Hungarian market. However, as a publicly traded company with a majority of revenue from exports, market-driven drug development remains the primary operating principle.

### What is the scale of Gedeon Richter's international manufacturing footprint?

Richter operates manufacturing sites in Hungary (Budapest, Debrecen, Dorog), Poland, Romania, and Russia, with distribution covering over 100 countries. Revenue is heavily skewed to international markets, with more than 90% generated outside Hungary. The firm's largest foreign markets include Russia, China, and the United States, supported by direct sales and marketing subsidiaries.

### Does Gedeon Richter engage in M&A or purely organic growth?

Richter pursues a mix of organic R&D and strategic acquisitions. Recent deal activity includes product portfolio purchases and licensing agreements in Western Europe and the US, such as the acquisition of branded women's health products for US market entry. The company also invests in biosimilar development partnerships rather than large-scale corporate M&A.

## Related profiles

- [KD Capital](https://altss.com/profile/kd-capital-llc)
- [Vibe Biotechnology](https://altss.com/profile/vibe-biotechnology-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/gedeon-richter

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology